Changes in polypeptide-specific factor VIII antigen levels during whole blood clotting

Area of Science:

• Biochemistry
• Hematology
• Molecular Biology

Background:

• Factor VIII (FVIII) is a critical protein in the coagulation cascade.
• Understanding FVIII proteolysis is key to comprehending hemostasis and thrombosis.
• Previous studies have not fully elucidated the kinetics of FVIII breakdown in whole blood.

Purpose of the Study:

• To investigate the time-course of factor VIII (FVIII) proteolysis during whole blood coagulation.
• To determine the role of thrombin generation in FVIII degradation.
• To compare FVIII proteolysis in normal subjects versus patients with coagulation disorders.

Main Methods:

• Development of polypeptide-specific enzyme-linked immunosorbent assays (ELISAs) using monoclonal antibodies against FVIII.
• Monitoring FVIII antigen (FVIII:Ag) levels and specific proteolytic fragments in whole blood over time.
• Analysis of FVIII proteolysis in response to calcium chloride and tissue thromboplastin.

Main Results:

• In normal whole blood, FVIII light and heavy chains degraded rapidly within 30 minutes, paralleling procoagulant activity.
• A 70 kDa thrombin-cleaved FVIII fragment persisted longer, with 75 U/dl FVIII:Ag remaining after 2 hours.
• Congenital hypoprothrombinemia showed a 20-minute lag before proteolysis, and prothrombin-depleted plasma lacked rapid FVIII degradation without thrombin generation.
• Tissue thromboplastin accelerated FVIII:Ag decrease, indicating rapid thrombin formation.

Conclusions:

• Thrombin generation is a prerequisite for factor VIII (FVIII) proteolysis during whole blood clotting.
• The rate of FVIII degradation is dependent on thrombin levels and activation pathways.
• These findings highlight the intricate relationship between thrombin and FVIII in coagulation regulation.